Experts Raise Red Flags Over US-Nigeria $600M Health Pact: Data Sharing and Funding Under Scrutiny!

Nigeria's health agreement with the United States, formalized through a Memorandum of Understanding (MoU) signed on December 19, 2025, has sparked significant debate and concern among prominent Nigerian figures and organizations. The agreement, set to run from April 2026 to December 2030, outlines a commitment from the United States to provide nearly $2 billion in grant funding over five years. In return, Nigeria has pledged to allocate at least six percent of its executed annual federal and state budgets to health, a move projected to mobilize nearly $3 billion in domestic health financing. The MoU encompasses critical areas such as disease surveillance, outbreak response, laboratory systems, support for frontline health workers, health information systems, and access to essential medical commodities.

However, Professor Oyewale Tomori, a virologist and former vice-chancellor of Redeemer’s University, has voiced strong reservations, warning that the agreement could entrench Nigeria's dependence on foreign assistance. Professor Tomori specifically highlighted concerns regarding data sharing and pathogen access, arguing that if Nigeria provides valuable health data and biological resources without guaranteed equitable benefit sharing, it may later be forced to purchase medicines, reagents, and other products developed from its own contributions. He stated that simply giving away health data and pathogens to America without benefit-sharing guarantees would perpetuate a cycle of dependence on external aid to address health challenges.

Professor Tomori also questioned the sustainability of Nigeria's financial commitments. He noted the country's historical struggles with low budgetary allocations and the timely release of approved funds, citing figures that only N36 million was released from a ₦218 billion health capital budget for 2025. He raised doubts about the government's capacity to mobilize the approximately $600 million annually required to meet its commitments while simultaneously addressing existing gaps in the health system. Furthermore, he cautioned that the US assistance, which primarily comprises materials, facilities, reagents, and drugs sourced from the American economy rather than direct cash transfers, could lead to Nigeria remaining reliant on American supplies even after the agreement's expiration, eventually having to finance such purchases itself.

On accountability, Tomori emphasized the need for Nigeria to strengthen its internal mechanisms for ensuring proper allocation and expenditure of public funds. He stressed that while the US would demand accountability for its contribution, Nigeria must take responsibility for monitoring its own spending and demonstrating measurable benefits from domestic resources. He added that despite existing institutions and procedures for accountable spending, the political will to enforce them has often been lacking. He also expressed concern about Nigeria’s technical capacity and institutional safeguards, noting that while the country possesses expertise, a sufficiently supportive environment for scientists, researchers, and health workers has not been created, with self-interest at various governance levels hindering national interests.

Echoing these concerns, the Northern States Christian Elders Forum (NOSCEF) has also expressed profound worry over the medical aid agreement, particularly regarding the supply of vaccines and medicines, Nigeria’s financial commitments, and the regulatory autonomy of the National Agency for Food and Drug Administration and Control (NAFDAC). NOSCEF chairman, Elder Sunday Oibe, demanded that the Federal Government clarify the financial implications of Nigeria's reported $2.1 billion counterpart contribution, the specific obligations of both nations, and the safeguards in place to protect Nigerian patients. The forum called for the full text of the agreement to be made public, especially clauses related to the testing, evaluation, approval, monitoring, and distribution of supplied medical products, urging the National Assembly to investigate the matter.

NOSCEF highlighted allegations that the agreement restricts NAFDAC from independently reviewing or testing supplied medical products, calling such provisions a grave concern for public health protection, regulatory independence, ethical responsibility, transparency, and national sovereignty. The forum insisted that NAFDAC's independence is paramount to safeguard Nigerians' health by ensuring that all regulated products meet safety, quality, and efficacy standards. It argued that no matter how generous the aid, Nigerians must not surrender independent oversight necessary for their protection.

The debate in Nigeria mirrors similar discussions across Africa, where other nations have also raised concerns over new bilateral health agreements with the United States under its “America First” global health strategy. Ghana, Zimbabwe, and Namibia have reportedly rejected proposed deals, while Kenya and Zambia have faced disputes over provisions concerning health data and biological specimens. Zimbabwe, for instance, withdrew from negotiations over a proposed $367 million agreement in February 2026, citing threats to its data sovereignty. Ghana declined a $109 million deal, also due to data sharing concerns, and Namibia similarly rejected a proposed agreement. Zambia, however, successfully finalized its agreement in October 2026 after contentious provisions requiring access to patient data and medical specimens were removed.

Despite these criticisms and the regional context, the Federal Government of Nigeria has defended the agreement as a crucial step towards bolstering health security, expanding primary healthcare, and building a more resilient and self-reliant health system. The government asserted that the partnership will support the early detection, prevention, and control of infectious diseases, including HIV/AIDS and tuberculosis, while improving laboratory systems, disease surveillance, and access to essential health commodities. Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, described the MoU as vital for safeguarding Nigerians' health and strengthening national resilience, underscoring a commitment to domestic investment, accountability, and long-term sustainability. The government maintains that progressively increasing domestic health financing as external grant support declines will facilitate a transition towards a sustainable health system by December 2030.